Scalable, Turn-key 3D Engineered Muscle Tissues for Drug Discovery

Time: 12:45 pm
day: Day One


  • Drug discovery for muscle indications often rely on direct measurement of muscle contractility, which is hard to measure in vitro.
  • We have developed a novel, label-free platform that easily fabricates and measures the contractility of complex 3D muscle tissue models.
  • The platform utilizes both primary and iPSC-derived cell lines, enabling facile disease modeling across a host of indications in skeletal and cardiac muscle diseases.